Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why do we need pharmacokinetic studies?

E F Hvidberg1

  • 1Department of Clinical Pharmacology, University Hospital, Copenhagen, Denmark.

American Journal of Obstetrics and Gynecology
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].

Ugeskrift for laeger·1994
Same author

Regulatory implications of good clinical practice. Towards harmonisation.

Drugs·1993
Same author

The antibacterial effect of some neuroleptics on strains isolated from patients with meningitis.

Pharmacology & toxicology·1992
Same author

Plasma, erythrocyte and urine concentrations of chlorproguanil and two metabolites in man after different doses.

The Journal of tropical medicine and hygiene·1991
Same author

Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells.

Pharmacology & toxicology·1991
Same author

Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.

Alimentary pharmacology & therapeutics·1990

Understanding human pharmacokinetics for sex steroids, including absorption and elimination, is crucial for predicting drug effects and ensuring patient safety. This data supports individualized treatment and regulatory approval for sex steroid therapies.

Area of Science:

  • Endocrinology and Pharmacology
  • Human Physiology

Background:

  • Comprehensive pharmacokinetic data for sex steroids in humans is limited.
  • Understanding drug absorption, distribution, clearance, and elimination is vital for predicting therapeutic effects.

Purpose of the Study:

  • To highlight the necessity of human pharmacokinetic data for sex steroids.
  • To emphasize the importance of this data for individualized treatment and regulatory evaluation.

Main Methods:

  • Review of existing literature and data on sex steroid pharmacokinetics.
  • Discussion of the application of descriptive, mathematical, and analytical approaches.
  • Emphasis on the integration of kinetic information into therapeutic strategies.

Main Results:

Related Experiment Videos

  • Pharmacokinetic data is essential for understanding sex steroid behavior in the human body.
  • Variability and dose-response correlations require multiple analytical approaches.
  • Regulatory authorities require human kinetic data for safety and efficacy assessments.

Conclusions:

  • Human pharmacokinetic data forms the foundation for safe and effective sex steroid treatments.
  • Individualized therapeutic regimens depend on accurate kinetic information.
  • Addressing data gaps in sex steroid pharmacokinetics is critical for advancing clinical practice.